Evidence map›Paper›PMID 28826662›Full record

ArticleJournal of molecular and cellular cardiology2017

Novel obscurins mediate cardiomyocyte adhesion and size via the PI3K/AKT/mTOR signaling pathway.

Maegen A Ackermann, Brendan King, Nicole A P Lieberman, Prameela J Bobbili, Michael Rudloff, Christopher E Berndsen, Nathan T Wright, Peter A Hecker, Aikaterini Kontrogianni-Konstantopoulos

Abstract read
In one paragraph

Article in Journal of molecular and cellular cardiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. A Novel Germline Frameshift Variant in the Tumor Suppressor GeneInternational journal of molecular sciences · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Understanding the molecular basis of cardiomyopathy.American journal of physiology. Heart and circulatory physiology · 2022
    Review
  10. Review
  11. Obscurin: A multitasking giant in the fight against cancer.Biochimica et biophysica acta. Reviews on cancer · 2021
    Review
  12. Article
  13. The M-band: The underestimated part of the sarcomere.Biochimica et biophysica acta. Molecular cell research · 2020
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Unraveling obscurins in heart disease.Pflugers Archiv : European journal of physiology · 2019
    Review
  19. Obscurin is a semi-flexible molecule in solution.Protein science : a publication of the Protein Society · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Maegen A AckermannDepartment of Biochemistry and Molecular Biology, University of Maryland, School of Medicine, Baltimore, MD 21201, United States; Department of Physiology and Cell Biology, Wexner College of Medicine, Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH 43210, United States. Electronic address: maegen.ackermann@osumc.edu.
Brendan KingDepartment of Biochemistry and Molecular Biology, University of Maryland, School of Medicine, Baltimore, MD 21201, United States.
Nicole A P LiebermanDepartment of Biochemistry and Molecular Biology, University of Maryland, School of Medicine, Baltimore, MD 21201, United States.
Prameela J BobbiliDepartment of Physiology and Cell Biology, Wexner College of Medicine, Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH 43210, United States.
Michael RudloffDepartment of Chemistry and Biochemistry, James Madison University, Harrisonburg, VA 22807, United States.
Christopher E BerndsenDepartment of Chemistry and Biochemistry, James Madison University, Harrisonburg, VA 22807, United States.
Nathan T WrightDepartment of Chemistry and Biochemistry, James Madison University, Harrisonburg, VA 22807, United States.
Peter A HeckerDivision of Cardiology and Department of Medicine, University of Maryland, Baltimore, MD 20201, United States.
Aikaterini Kontrogianni-KonstantopoulosDepartment of Biochemistry and Molecular Biology, University of Maryland, School of Medicine, Baltimore, MD 21201, United States. Electronic address: akontrogianni@som.umaryland.edu.
University of Maryland, Baltimore · USJames Madison University · USThe Ohio State University Wexner Medical Center · US

Funding

Novel Locations; Familiar Functions: Obscurin at the Cardiac Intercalated DiscR00HL116778 · NHLBI · OHIO STATE UNIVERSITY · PI BORZOK, MAEGEN A. · 2016 to 2018
$729k
Novel Locations; Familiar Functions: Obscurin at the Cardiac Intercalated DiscK99HL116778 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI BORZOK, MAEGEN A. · 2013 to 2014
$257k
NHLBI NIH HHS K99 HL116778NHLBI NIH HHS R00 HL116778
6 · The paper itself

Abstract

The intercalated disc of cardiac muscle embodies a highly-ordered, multifunctional network, essential for the synchronous contraction of the heart. Over 200 known proteins localize to the intercalated disc. The challenge now lies in their characterization as it relates to the coupling of neighboring cells and whole heart function. Using molecular, biochemical and imaging techniques, we characterized for the first time two small obscurin isoforms, obscurin-40 and obscurin-80, which are enriched at distinct locations of the intercalated disc. Both proteins bind specifically and directly to select phospholipids via their pleckstrin homology (PH) domain. Overexpression of either isoform or the PH-domain in cardiomyocytes results in decreased cell adhesion and size via reduced activation of the PI3K/AKT/mTOR pathway that is intimately linked to cardiac hypertrophy. In addition, obscurin-80 and obscurin-40 are significantly reduced in acute (myocardial infarction) and chronic (pressure overload) murine cardiac-stress models underscoring their key role in maintaining cardiac homeostasis. Our novel findings implicate small obscurins in the maintenance of cardiomyocyte size and coupling, and the development of heart failure by antagonizing the PI3K/AKT/mTOR pathway.

Indexed as

Cell SizeSignal TransductionAcute DiseaseAlternative SplicingAnimalsCell AdhesionCells, CulturedChronic DiseaseDisease Models, AnimalGuanine Nucleotide Exchange FactorsHeart FailureMice, Inbred C57BLMuscle ProteinsMyocytes, CardiacPhosphatidylinositol 3-KinasesPhosphatidylinositol PhosphatesGuanine Nucleotide Exchange FactorsMuscle Proteinsobscn protein, mousephosphatidylinositol 3,4-diphosphatePhosphatidylinositol 3-KinasesPhosphatidylinositol PhosphatesProtein IsoformsProtein Serine-Threonine KinasesProto-Oncogene Proteins c-aktRho Guanine Nucleotide Exchange FactorsTOR Serine-Threonine KinasesIntercalated discObscurinPhosphatidyl-inositol bisphosphatesPI3K/AKT/mTORPleckstrin homology domain

Identifiers

PMID28826662
PMCPMC5694667
OpenAlexW2743028599

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.